← Evidence map

ArticleJACC. Basic to translational science2023

Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use-Patient Harms and Prescriber Responsibilities.

Gail A Van NormanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

31 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36908673